Clinical Trial Update: Phase II Trial of Disulfiram With Copper in Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

A Phase II clinical trial evaluating disulfiram in combination with copper for metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Disulfiram with Copper (Disulfiram)

Snippet

Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic | Conditions: Breast Neoplasm Female, Metastatic Breast Cancer | Phase 2 | Status: RECRUITING